Antibiotics of the virginiamycin family, inhibitors which contain synergistic components.
about
Synergy and contingency as driving forces for the evolution of multiple secondary metabolite production by Streptomyces speciesPotential of Biological Processes to Eliminate Antibiotics in Livestock Manure: An OverviewCombination therapies for combating antimicrobial resistanceStructural basis for streptogramin B resistance in Staphylococcus aureus by virginiamycin B lyaseSynergy of Streptogramin Antibiotics Occurs Independently of Their Effects on TranslationPurification and characterization of virginiamycin M1 reductase from Streptomyces virginiae.Characterization of the 'pristinamycin supercluster' of Streptomyces pristinaespiralis.Identification of a streptogramin A acetyltransferase gene in the chromosome of Yersinia enterocolitica.Characterization of a variant of vga(A) conferring resistance to streptogramin A and related compoundsCharacterization of binding sequences for butyrolactone autoregulator receptors in streptomycetes.Comparative in vitro activities of pristinamycin, its components, and other antimicrobial agents against anaerobic bacteriaPapR6, a putative atypical response regulator, functions as a pathway-specific activator of pristinamycin II biosynthesis in Streptomyces pristinaespiralisAntimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria.Diversity among the gram-positive acetyltransferases inactivating streptogramin A and structurally related compounds and characterization of a new staphylococcal determinant, vatBStereospecific reduction of virginiamycin M1 as the virginiamycin resistance pathway in Streptomyces virginiae.Distribution of genes encoding resistance to streptogramin A and related compounds among staphylococci resistant to these antibiotics.Comparative in vitro activities of pristinamycin and other antimicrobial agents against genital pathogens.Involvement of the TetR-Type Regulator PaaR in the Regulation of Pristinamycin I Biosynthesis through an Effect on Precursor Supply in Streptomyces pristinaespiralis.Identification of the satA gene encoding a streptogramin A acetyltransferase in Enterococcus faecium BM4145.Analysis of pristinamycin-resistant Staphylococcus epidermidis isolates responsible for an outbreak in a Parisian hospital.Natural campylobacter colonization in chickens raised under different environmental conditions.Lasting damage to bacterial ribosomes by reversibly bound virginiamycin M.Antibiotic resistance in Escherichia coll and Enterococcus spp. isolates from commercial broiler chickens receiving growth-promoting doses of bacitracin or virginiamycin.Antimicrobial susceptibility of ileal symbiont intracellularis isolated from pigs with proliferative enteropathy.Cloning and analysis of structural genes from Streptomyces pristinaespiralis encoding enzymes involved in the conversion of pristinamycin IIB to pristinamycin IIA (PIIA): PIIA synthase and NADH:riboflavin 5'-phosphate oxidoreductase.In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococciMerging chemical ecology with bacterial genome mining for secondary metabolite discoveryα,β-Dehydroamino acids in naturally occurring peptides.Tn5406, a new staphylococcal transposon conferring resistance to streptogramin a and related compounds including dalfopristin.Streptogramin B biosynthesis in Streptomyces pristinaespiralis and Streptomyces virginiae: molecular characterization of the last structural peptide synthetase gene.Purification of the two-enzyme system catalyzing the oxidation of the D-proline residue of pristinamycin IIB during the last step of pristinamycin IIA biosynthesis.Purification of peptide synthetases involved in pristinamycin I biosynthesis.Pristinamycin I biosynthesis in Streptomyces pristinaespiralis: molecular characterization of the first two structural peptide synthetase genesChemical probing of a virginiamycin M-promoted conformational change of the peptidyl-transferase domainA Complex Signaling Cascade Governs Pristinamycin Biosynthesis in Streptomyces pristinaespiralis.Linkage of vat(E) and erm(B) in streptogamin-resistant Enterococcus faecium isolates from Europe.Antibiotic growth promoters virginiamycin and bacitracin methylene disalicylate alter the chicken intestinal metabolome.
P2860
Q24619436-42A3CCBC-50D5-4DE1-8F87-05DD68976938Q26864509-07AEAF57-10A5-44BA-94DC-F8D49E930E21Q27015710-C82319F4-7EB8-4485-8D65-65C424098452Q27645655-9DB88049-6A28-4278-8832-682CFF047216Q27684447-45BA3736-9C57-44B6-BE0D-606568DD1448Q33701807-A788B894-CDCA-49BE-BD60-0A50D4CB0172Q33826781-FF00FE55-ABE3-4253-A16E-99E447835AA2Q33979098-009117BB-0DA2-4457-A76B-3CCD401B2896Q33980386-AD29D004-D620-40EA-A1D7-65801547B808Q33992745-21D149A3-DCA8-4DEB-8721-A2E886843EA2Q34167712-62AE908B-7F4F-46B3-AC98-AA9DEC51FD05Q34853398-E9B08E3F-DE8F-41F7-B599-BF4BA2EEF715Q34927077-CC7AAB16-5AD2-4DE7-811E-B5D744B73355Q35118379-6D260896-03E8-494A-B369-B8E0912F7E27Q35122918-886667C2-10A9-4F3E-9951-4774F09D94D7Q35128993-D0C554B5-6E60-46BD-8DB5-34DA34376ACBQ35364707-6FBE9955-588F-446F-9BF1-CA5C15B57545Q35625997-49233A61-1693-4972-9B01-1615D2BED6C6Q35897331-BC2759E0-E12C-4FD0-AFA3-EB9CCC7732AEQ35897404-94DF262C-ED72-4CC8-A2F2-89ED967FE6B8Q36250546-7671A5E4-2264-4E52-9C29-3DBABE9E8190Q36407325-891337E3-AC7C-4BBB-B341-02BAE189DC79Q36513615-91D89573-B433-4702-A5FC-4B2FFD2A8703Q36522028-B5165DBA-AF1E-48BE-ABC0-9E4355A3DB39Q36693534-4E9F8287-4280-4FB5-A588-D44B8C4E104AQ36753160-B71C808D-45D8-4644-BA35-F651E1AA0AEFQ37625358-9E9622E9-FE16-4A15-81E9-3E8FD025E898Q38260920-6BDB465E-1150-4072-AFBC-760B60B4284FQ39652567-562C7E25-B7AC-40BD-A5CE-BA6F6FC08761Q39784851-EC1A99D6-9F8E-4DF9-9C33-F47E318FE7BCQ39838275-F7012C44-6819-458D-9039-728880908B61Q39844201-3EA55A17-B0DD-4A54-970E-B8D314AAE06DQ39844206-B07FF2A0-AA9A-4685-ACC8-70CC9025C051Q40401781-836CA932-E5C3-452C-8546-E83465990E03Q41101916-B2BBA7C1-0AFA-4B63-BC51-02979EF63255Q42729934-6236E0C2-A7FC-48F5-A65C-EEF8CF46575EQ50336319-AF92FFE9-7979-49C6-8BA3-BD8A9CDE2CF3
P2860
Antibiotics of the virginiamycin family, inhibitors which contain synergistic components.
description
1979 nî lūn-bûn
@nan
1979 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
name
Antibiotics of the virginiamycin family, inhibitors which contain synergistic components.
@ast
Antibiotics of the virginiamycin family, inhibitors which contain synergistic components.
@en
type
label
Antibiotics of the virginiamycin family, inhibitors which contain synergistic components.
@ast
Antibiotics of the virginiamycin family, inhibitors which contain synergistic components.
@en
prefLabel
Antibiotics of the virginiamycin family, inhibitors which contain synergistic components.
@ast
Antibiotics of the virginiamycin family, inhibitors which contain synergistic components.
@en
P2860
P1476
Antibiotics of the virginiamycin family, inhibitors which contain synergistic components.
@en
P2093
P2860
P304
P577
1979-06-01T00:00:00Z